Menu
Biotechnology
200
Muscular dystrophies have long been a devastating and debilitating condition, leaving individuals and their families with limited treatment options and a bleak outlook. However, modern sciences like genetic engineering and biotechnology are ushering in a new era of hope. One such organization named Dyne Therapeutics is employing these innovative sciences to significantly improve the quality of life for patients and their loved ones.
Founded in 2018, Dyne Therapeutics is a biotechnology company that has been making waves in the field of genetic medicines with its innovative approaches to developing therapies for patients with serious muscle disorders. Based in Waltham, Massachusetts, the company is dedicated to harnessing the power of its proprietary FORCE™ platform to create next-generation oligonucleotide therapeutics that can target previously undruggable muscle tissues. Drawing upon the expertise of a team of about 200 seasoned scientists and biotech professionals, Dyne Therapeutics has quickly emerged as a leader in its field, garnering significant attention from investors and industry insiders alike. The company also has a separate board of directors and a scientific advisory board to assist their decision-making based on expertise and priority.
As Dyne Therapeutics continues to grow by adding more expert minds to its workforce, the company was making considerable progress in tackling rare but debilitating muscular diseases such as DM1 (myotonic dystrophy type 1), DMD (Duchenne muscular dystrophy), and FSHD (facioscapulohumeral muscular dystrophy). However, the company’s rapid growth was also posing challenges for its HR and IT teams. While the company’s sole focus on genetic medicines and oligonucleotide therapeutics already made talent acquisition a significant challenge for the HR department, managing employee lifecycle events was becoming too cumbersome.
The manual processes involved in updating data from their HRIS ADP to AD (Active Directory) were not only time-consuming but also prone to errors and lacked the scalability required for a rapidly growing organization. Additionally, the evolving leadership was making it difficult for its Sysadmin to keep up with employee onboarding, offboarding, role changes, and Global Address List (GAL) updates. To overcome these challenges, Dyne Therapeutics recognized the need for an automated solution. They needed a solution that could streamline workflows, provide a better experience for employees, and ensure that IT operations were effective and secure enough to adhere to health industry regulations and data privacy compliances.
Dyne Therapeutics‘ search for an automation solution led them to RoboMQ, a leading integration platform as a service (iPaaS) provider that has been accelerating digital transformation for enterprises through data and API integration for over a decade now. Its Prepackaged Integration Product– Hire2Retire, has helped many companies achieve end-to-end automation in their various HR and IT operations. Dyne Therapeutics, too, is now using Hire2Retire to-
Biotechnology
200
Hudson Headwaters Health Network enables better patient experience by building prompt & secure role-based access to patient…Know More
As a pre-packaged integration solution, Hire2Retire helped 908 Devices to efficiently onboard and offboard…Know More
OrthoIndy, a leading orthopaedic practice across multiple locations in the Midwest, enabled role based secure and…Know More